Recent 8-K filings for TMO

• April 23, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases

  Thermo Fisher Q1 revenue $11.01B (+6% YoY); adjusted EPS $5.44 (+6%)

  Q1 revenue $11.01B, up 6% YoY; organic revenue growth 1%.

• February 12, 2026, 6:59 PM ET debt materiality 0.75 neutral item 1.01item 8.01item 9.01 ◈ Material Agreements

  Thermo Fisher issues $3.8B in senior notes to partially fund Clario acquisition

  Issued four tranches: $1B 4.215% Notes due 2031, $750M 4.550% due 2033, $1.3B 4.902% due 2036, $750M 5.546% due 2046.

• January 29, 2026, 6:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01

  Thermo Fisher Q4 rev $12.21B (+7%), adj EPS $6.57 (+8%); FY rev $44.56B (+4%)

  Q4 GAAP diluted EPS $5.21 (+9%); adj EPS $6.57 (+8%); GAAP operating margin 18.5%.

• January 12, 2026, 6:59 PM ET leadership materiality 0.60 neutral item 5.02

  Thermo Fisher EVP/COO Lagarde and EVP Lowery to depart; Pettiti promoted to President and COO

  Michel Lagarde, EVP & COO, leaves March 31, 2026; Frederick Lowery, EVP, leaves Feb 28, 2026.

• October 29, 2025, 7:59 PM ET M&A materiality 0.75 neutral item 8.01item 9.01

  Thermo Fisher to acquire Clario Holdings for $8.875B; deal expected to close mid-2026

  $8.875B cash at closing; additional $125M deferred and up to $400M contingent consideration.

• October 22, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Thermo Fisher Q3 revenue $11.12B (+5%); adjusted EPS $5.79 (+10%)

  Revenue $11.12B, +5% reported and +3% organic; GAAP EPS $4.27 vs $4.25 YoY.

• July 23, 2025, 7:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01

  Thermo Fisher Q2: rev +3% to $10.85B, GAAP EPS $4.28 (+6%), adj EPS $5.36

  Q2 revenue $10.85B (+3% YoY; organic 2%); GAAP diluted EPS $4.28, up 6% from $4.04.

• July 23, 2025, 7:59 PM ET leadership materiality 0.60 neutral item 5.02

  Thermo Fisher CFO Stephen Williamson to retire March 2026; James Meyer named successor

  CFO Stephen Williamson will retire effective March 31, 2026.

• May 22, 2025, 7:59 PM ET other material materiality 0.70 positive item 5.02item 9.01

  Thermo Fisher grants CEO Casper $60M performance RSU award with TSR-based vesting through 2030

  Target award of 141,538 shares (~$60M) to CEO Marc Casper; cliff vesting May 21, 2030 contingent on TSR vs S&P 500.

• April 23, 2025, 7:59 PM ET earnings materiality 0.85 positive item 2.02item 9.01

  Thermo Fisher Q1 GAAP EPS $3.98 (+15%), revenue $10.36B; agrees to acquire Solventum biz for $4.1B

  Q1 revenue $10.36B (+0.2% YoY); organic growth 1%; GAAP diluted EPS $3.98 (+15%).

• February 25, 2025, 6:59 PM ET M&A materiality 0.80 positive item 8.01

  Thermo Fisher to acquire Solventum's purification and filtration business for $4.1B

  Deal value approximately $4.1 billion in cash.

• January 30, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Thermo Fisher Q4 revenue $11.40B (+5%), adj. EPS $6.10 (+8%)

  Q4 GAAP diluted EPS $4.78 (+14% YoY); adjusted EPS $6.10 (+8% YoY).

• October 23, 2024, 7:59 PM ET earnings materiality 0.65 neutral item 2.02item 9.01

  Thermo Fisher Q3 revenue flat at $10.60B; adjusted EPS $5.28; raises FY adjusted EPS guidance

  Revenue $10.60B, essentially flat versus $10.57B in Q3 2023; organic revenue also flat.

• July 24, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Thermo Fisher Q2 GAAP EPS $4.04 (+15%), Adj. EPS $5.37 (+4%), raises FY 2024 guidance

  Revenue $10.54B, down 1% YoY; organic revenue -1%, core organic revenue flat.

• April 24, 2024, 7:59 PM ET earnings materiality 0.82 positive item 2.02item 9.01 ◈ Earnings Releases

  Thermo Fisher Q1 rev $10.34B (-3%), GAAP EPS $3.46 (+4%), raises FY guidance

  GAAP diluted EPS $3.46 vs $3.32 YoY; adjusted EPS $5.11 vs $5.03 (+2%).

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.68 · Most common event earnings

9 positive 2 negative 13 neutral

source · TMO on sec.gov